Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP/PKA signalling pathway.
about
Neurological phenotypes for Down syndrome across the life spanPrimary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and TreatmentRedox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain.Impact of repeated stress on traumatic brain injury-induced mitochondrial electron transport chain expression and behavioral responses in rats.Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome.Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies.Mitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin.Lymphocyte respiration in children with Trisomy 21A Female Patient with Down Syndrome and Low-Penetrance Leber's Hereditary Optic Neuropathy.Intracellular oxidant activity, antioxidant enzyme defense system, and cell senescence in fibroblasts with trisomy 21.Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia.Oxidative Stress and Mitochondrial Dysfunction in Down's Syndrome: Relevance to Aging and DementiaAntioxidants in Down syndrome.Adaptive downregulation of mitochondrial function in down syndromeAnti-photoaging properties of the phosphodiesterase 3 inhibitor cilostazol in ultraviolet B-irradiated hairless micecAMP and mitochondria.Respiratory chain complex I, a main regulatory target of the cAMP/PKA pathway is defective in different human diseases.From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease.The contribution of the citrate pathway to oxidative stress in Down syndrome.Resveratrol and Brain Mitochondria: a Review.Increased non-protein bound iron in Down syndrome: contribution to lipid peroxidation and cognitive decline.Mitochondrial dysfunction and potential anticancer therapy.Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism.Protein Kinase A Governs Oxidative Phosphorylation Kinetics and Oxidant Emitting Potential at Complex I.Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo.Melanocortin 4 receptors in the paraventricular nucleus modulate the adipose afferent reflex in rat.DNA methyltransferase 1 mutations and mitochondrial pathology: is mtDNA methylated?Melanocortin 3/4 receptors in paraventricular nucleus modulate sympathetic outflow and blood pressure.Metabolic and Growth Rate Alterations in Lymphoblastic Cell Lines Discriminate Between Down Syndrome and Alzheimer's Disease.An overview about oxidation in clinical practice of skin aging.Oxysterol-induced apoptosis of smooth muscle cells is under the control of a soluble adenylyl cyclase.Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets.Chronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defects
P2860
Q27025698-F1A143AB-B325-4C69-B98E-9A2EAF803439Q28078384-EDB91E4C-AA2B-406F-846D-2E908B8DDAA4Q30367032-7C2E4E2B-491D-4885-90DD-64C555BD991EQ30445368-1F4B6068-6040-4325-8B6C-9EE1799DD075Q30653697-2C1C6EC5-15B9-4E44-A49E-713FEC987552Q33625254-8B137897-3F38-4192-A99D-B4D142A8CFE3Q34243380-4C34F505-5582-4E8A-863F-7A419FCA6A76Q34515043-64B83DAC-5429-445E-BFA7-0DAE03CC9142Q34792126-BC36C19A-ED86-40B4-8A08-EBD8DAA02853Q35234195-53E388B5-646F-4622-B647-D858F8D70089Q35606429-1D062086-8850-4EF5-992E-E28E8509F882Q35955120-3EDEF083-EFB6-4686-BAF2-4EAD26AB28E5Q36126681-92B66740-FD65-4000-B377-BF8AFD1E60E3Q36632280-0BC9D42C-138C-45FD-BAB2-A3483A0F6330Q37147840-3F8FC2AE-5E81-4C7B-864E-B84DF585D6BEQ37408572-ABAF5291-A75B-45A7-9A35-3BB1FDA070B4Q37938299-E9E5EE65-E94F-486B-A9AC-310394DBDC7BQ38029575-280B2512-737C-4C36-B8E3-AF4641B281FDQ38733639-AA8BD19A-01EF-44FC-972E-969140BC0C78Q39173672-82817E77-783E-49F7-9609-0B60EEBD4B29Q39244955-C1324B65-FBF8-470C-BC31-095627EC49C0Q39418003-F38E0CD3-2EB9-4E6A-8D57-0B6933C7457FQ39433562-8BAA5F3E-2A5A-41E0-8EC2-B48190EB972EQ40243458-BEE2266A-DCB2-4EF2-BC07-122A672420BDQ41856729-412E0C40-CA62-4EAB-BC59-D4B5CA6CC128Q42913510-0C2764CF-AEAC-4569-AEA6-122FCEAC6C7EQ43184131-FE8C3B51-23AF-4BDC-88B0-26CA46A89BEBQ44523641-72B643C7-4514-475D-8655-E15FA3F33D3EQ44881513-E5FE3D7C-4E9A-4442-8538-207BF2015AB7Q46252019-4BC04A31-4640-4E2C-8949-E101FE1C8AC2Q50942948-D41B1ECD-CBB5-4F02-B141-DA83A4429822Q55502644-42FFE27B-3630-4644-BD78-52E4CCA49CEEQ58816207-7BABDC6B-BA2C-4ABD-9DA2-8BE3BDB41EEC
P2860
Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP/PKA signalling pathway.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Deficit of complex I activity ...... e cAMP/PKA signalling pathway.
@en
Deficit of complex I activity ...... e cAMP/PKA signalling pathway.
@nl
type
label
Deficit of complex I activity ...... e cAMP/PKA signalling pathway.
@en
Deficit of complex I activity ...... e cAMP/PKA signalling pathway.
@nl
prefLabel
Deficit of complex I activity ...... e cAMP/PKA signalling pathway.
@en
Deficit of complex I activity ...... e cAMP/PKA signalling pathway.
@nl
P2860
P50
P356
P1433
P1476
Deficit of complex I activity ...... he cAMP/PKA signalling pathway
@en
P2093
Ersilia Marra
Gabriella Arcangela Manente
P2860
P304
P356
10.1042/BJ20101908
P407
P577
2011-05-01T00:00:00Z